A specific gene expression signature characterizes metastatic potential in clear cell renal cell carcinoma

Journal of Urology

Volumn 186, Issue 1, 2011, Pages 289-294

  Sanjmyatav, Jimsgene ^a   Steiner, Thomas ^a   Wunderlich, Heiko ^a   Diegmann, Julia ^b   Gajda, Mieczyslaw ^a   Junker, Kerstin ^a  

^a JENA UNIVERSITY HOSPITAL   (Germany)

^b Institute of Human Genetics and Anthropology   (Germany)

Author keywords

carcinoma; genetic markers; kidney; neoplasm metastasis; prognosis; renal cell

Indexed keywords

BIOLOGICAL MARKER; CD151 ANTIGEN; I KAPPA B ALPHA; MATRIX METALLOPROTEINASE 16; PROGRAMMED DEATH 1 LIGAND 1; PROTEIN BCL 2; TRANSCRIPTION FACTOR FRA 2;

ADULT; AGED; ARTICLE; CLEAR CELL CARCINOMA; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION PROFILING; GENE LOCATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; KIDNEY PARENCHYMA; MALE; METASTASIS; MICROARRAY ANALYSIS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, RENAL CELL; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS;

EID: 79958289707     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2011.03.033     Document Type: Article

References (30)

1. A. Jemal, R. Siegel, and E. Ward Cancer statistics, 2009 CA Cancer J Clin 59 2009 225
2. J.J. Patard, E. Leray, and N. Rioux-Leclercq Prognostic value of histologic subtypes in renal cell carcinoma: a multicenter experience J Clin Oncol 23 2005 2763
3. J.C. Cheville, C.M. Lohse, and H. Zincke Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma Am J Surg Pathol 27 2003 612
4. R.A. Figlin Renal cell carcinoma: management of advanced disease J Urol 161 1999 381
5. Y.H. Yang, S. Dudoit, and P. Luu Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation Nucleic Acids Res 30 2002 e15
6. J. Vandesompele, K. De Preter, and F. Pattyn Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes Genome Biol 3 2002 research0034
7. M. Takahashi, D.R. Rhodes, and K.A. Furge Gene expression profiling of clear cell renal cell carcinoma: gene identification and prognostic classification Proc Natl Acad Sci USA 98 2001 9754
8. J.R. Vasselli, J.H. Shih, and S.R. Iyengar Predicting survival in patients with metastatic kidney cancer by gene-expression profiling in the primary tumor Proc Natl Acad Sci USA 100 2003 6958
9. F. Kosari, A.S. Parker, and D.M. Kube Clear cell renal cell carcinoma: gene expression analyses identify a potential signature for tumor aggressiveness Clin Cancer Res 11 2005 5128
10. H. Zhao, B. Ljungberg, and K. Grankvist Gene expression profiling predicts survival in conventional renal cell carcinoma PLoS Med 3 2006 e13
11. J. Jones, H. Otu, and D. Spentzos Gene signatures of progression and metastasis in renal cell cancer Clin Cancer Res 11 2005 5730
12. H. Sltmann, A. von Heydebreck, and W. Huber Gene expression in kidney cancer is associated with cytogenetic abnormalities, metastasis formation, and patient survival Clin Cancer Res 11 2005 646
13. M. Nogueira, and H.L. Kim Molecular markers for predicting prognosis of renal cell carcinoma Urol Oncol 26 2008 113
14. C.P.Y. Kwak, C.W. Jeong, and H. Jeong Characteristics of metastasis as a prognostic factor for immunotherapy in metastatic renal cell carcinoma Tumori 93 2007 68
15. H.S. Hofmann, H. Neef, and K. Krohe Prognostic factors and survival after pulmonary resection of metastatic renal cell carcinoma Eur Urol 48 2005 77
16. H. Dong, S. Strome, and D. Salomao Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion Nat Med 8 2002 793
17. J. Brown, D. Dorfman, and F. Ma Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production J Immunol 170 2003 1257
18. R. Thompson, M. Gillett, and J. Cheville Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic target Proc Natl Acad Sci USA 101 2004 17174
19. A. Krambeck, H. Dong, and R. Thompson Survivin and b7-h1 are collaborative predictors of survival and represent potential therapeutic targets for patients with renal cell carcinoma Clin Cancer Res 13 2007 1749
20. F. Hirano, K. Kaneko, and H. Tamura Blockade of B7-H1 and PD-1 by monoclonal antibodies potentiates cancer therapeutic immunity Cancer Res 65 2005 1089
21. G. Gobe, M. Rubin, and G. Williams Apoptosis and expression of Bcl-2, Bcl-XL, and Bax in renal cell carcinomas Cancer Invest 20 2002 324
22. C. Simpson, K. Anyiwe, and A. Schimmer Anoikis resistance and tumor metastasis Cancer Lett 272 2008 177
23. H. van Dam, and M. Castellazzi Distinct roles of Jun: Fos and Jun:ATF dimers in oncogenesis Oncogene 20 2001 2453
24. H. Andersen, S. Mahmood, and V. Tkach The ability of Fos family members to produce phenotypic changes in epithelioid cells is not directly linked to their transactivation potentials Oncogene 21 2002 4843
25. C. Schrder, U. Schumacher, and V. Mller The transcription factor Fra-2 promotes mammary tumour progression by changing the adhesive properties of breast cancer cells Eur J Cancer 46 2010 1650
26. J. Johnson, N. Winterwood, and K. DeMali Tetraspanin CD151 regulates RhoA activation and the dynamic stability of carcinoma cell-cell contacts J Cell Sci 122 2009 2263
27. R. Sadej, H. Romanska, and G. Baldwin CD151 regulates tumorigenesis by modulating the communication between tumor cells and endothelium Mol Cancer Res 7 2009 787
28. T. Tokuhara, H. Hasegawa, and N. Hattori Clinical significance of CD151 gene expression in non-small cell lung cancer Clin Cancer Res 7 2001 4109
29. J. Ang, M. Lijovic, and L. Ashman CD151 protein expression predicts the clinical outcome of low-grade primary prostate cancer better than histologic grading: a new prognostic indicator? Cancer Epidemiol Biomarkers Prev 13 2004 1717
30. C. Hirano, M. Nagata, and A. Noman Tetraspanin gene expression levels as potential biomarkers for malignancy of gingival squamous cell carcinoma Int J Cancer 124 2009 2911